Product Reports Resources Pricing Login Book a demo
COMPANY PROFILE

Blueprint

Explore full profile

Precision health system optimizing longevity through data-driven protocols

Los Angeles, United StatesFounded 2021Biotech & Life Sciences
Valuation $250–500M Last recorded · 2025
Headcount 100–500 Current team size
Total funding $50–100M Disclosed equity funding
Unlock exact values This page shows ranges. Dealroom has the exact numbers for Blueprint and the history behind them.

About Blueprint

Blueprint is a health and longevity system based on the personal anti-aging protocol of its founder, Bryan Johnson. The company was created in 2020 following Johnson's multi-year, multi-million dollar self-experiment, Project Blueprint, which aims to slow and reverse the aging process through a data-driven regimen. The business productizes Johnson's protocol by selling meticulously sourced food products, such as olive oil, and proprietary dietary supplements like a 'Longevity Mix'. The target market includes individuals interested in health optimization and longevity.

The company's business model is direct-to-consumer e-commerce, selling its products through its official website. The core of the Blueprint protocol involves a strict diet, targeted supplementation, specific exercise routines, and comprehensive tracking of over 100 biomarkers to inform and adjust the regimen. Johnson makes his personal protocol, measurements, and results publicly available as a free resource to guide others. The project has gained significant media attention and a large social media following.

Bryan Johnson is a tech entrepreneur who founded the payment processing company Braintree in 2007, which he later sold to PayPal in 2013 for $800 million after it had acquired Venmo. This exit provided him with the capital for his subsequent ventures. Before Blueprint, Johnson founded OS Fund in 2014, a venture capital firm investing in early-stage science and technology companies, and Kernel in 2016, a neurotechnology company developing non-invasive brain-monitoring hardware. His journey into extreme biohacking was reportedly preceded by a period of depression and health struggles. As of mid-2025, reports indicated Johnson was considering selling or shutting down Blueprint to focus on a broader life extension philosophy called "Don't Die", citing that the business aspect was diminishing his credibility on the philosophical side.

Source: Dealroom company data

At a glance

Status
Operational
Founded
2021
Headquarters
Los Angeles, United States
Employees
124
Open positions
None listed
Dealroom signal
90.7/100
Industry
Health
Sub-industry
Pharmaceutical
Sector
Biotech & Life Sciences, Dietary Supplements, Biotechnology, Biomarkers, Nutrition, Longevity
Technology
Artificial Intelligence, Machine Learning
Business model
Manufacturing
Client focus
b2b, b2c

Funding history

2 recorded events

Company financing events and reported valuations.

Deal typeDateAmountValuationInvestorsSource
SEEDOther financing Dec 2025 — — North Island Ventures ↗
ANGELOther financing Oct 2025 $60M $240M Joe Gebbia · Balaji Srinivasan · Emmett Shear · Dave Morin ↗
Showing the latest 2 of 2 recorded eventsBook a demo for the full funding history →

Growth signals

Blueprint website traffic

Latest recorded traffic for Blueprint is 90 monthly website visits, down 76.3% over the last three months. Blueprint's team grew 63.2% over the past year.

Latest monthly visits90 3-month web change-76.3% 1-year team growth+63.2%
Summary metrics are public; monthly history is available with a demoCompare with peers →

Similar companies

Closest operating peers by Dealroom taxonomy

Company identity and context are open; selected comparison metrics preview what is available on the platform.

Showing 8 of the closest matchesCompare every metric →

Investments and acquisitions

Capital deployed

Recent portfolio relationships for companies that also act as investors or acquirers.

Investors

46 investors on the cap table

From Dealroom's funding and investor records, grouped by the round each investor first entered.

Seed46 investors entered at this stage

  • Joe Gebbia
  • Balaji Srinivasan
  • Emmett Shear
  • Dave Morin
  • Drew Houston
  • Joe Lonsdale
  • Joshua Kushner
  • Brad Keywell
  • Kyle Widrick
  • Suna Said
  • Bryan Meehan
  • Fareed Adib
  • Carter Reum
  • Gregg Rosenthal
  • Wojciech Zaremba
  • Pippa Lamb
  • Michael Kives
  • Saquon Barkley
  • Seth Bannon
  • Paris Hilton
  • Don Wilson
  • John Carmack
  • Alex Hormozi
  • Jay Shetty
  • Amanda Cassatt
  • Olaf Carlson-Wee
  • Cameron Winklevoss
  • Tyler Winklevoss
  • Jason Fried
  • Jaan Tallinn
  • Kevin Hartz
  • Naval Ravikant
  • Chris Hollod
  • Ariel Emanuel
  • Eric Demuth
  • Kamal Ravikant
  • Kim Kardashian
  • Karim Beguir
  • Steve Aoki
  • Logan Paul
  • Shayne Coplan
  • Steven Bartlett
  • Dan Manges
  • Akshay BD
  • Andrej Karpathy
  • North Island Ventures
Team profiled 9 named & role-tagged
Founders Hidden — book a demo/100 quality score
Key operators 4 quality Hidden — book a demo/100
Potential founders Hidden — book a demo likely future founders
Startup mafia Hidden — book a demo alumni-founded startups
Talent movements Hidden — book a demo in · Hidden — book a demo out past 12 months

Source: Dealroom Talent Intelligence.

Global footprint

Workforce and web traffic by country
Workforce by country
11 countries with
team presence
🇺🇸 United States82.2%
🇩🇪 Germany4.4%
🇬🇧 United Kingdom3.3%
🇨🇦 Canada2.2%
🇵🇱 Poland1.1%
Top 5 of 11 shown

Market sentiment

Posts on X, past 7 days

An AI-synthesised read of the highest-engagement posts about Blueprint on X, ranked by likes and reposts, corporate channels excluded.

Reading the room on X — pulling top posts and synthesizing themes…

Source: X recent search ranked by engagement (likes + retweets) · Synthesis by Claude · Cached for 1 hour

See Blueprint’s full profile on Dealroom

Request a free trial to see the complete deal history, financials, people graph and growth signals.

Takes under a minute. Already use Dealroom? Log in.